E-LIB Suche - Ergebnisse für: Shitara, Kohei

1

Clinical practice guidelines for esophagogastric junction c..:

Kitagawa, Yuko ; Matsuda, Satoru ; Gotoda, Takuji...
https://cris.maastrichtuniversity.nl/en/publications/f765e8fb-0b97-4694-be0b-922d1dd6331c. , 2024

Link: https://cris.maastrichtu..

2

Clinical practice guidelines for esophagogastric junction c..:

Kitagawa, Yuko ; Matsuda, Satoru ; Gotoda, Takuji...
https://pure.eur.nl/en/publications/10072edf-e4af-4e63-b38f-8317ebd73894. , 2024

Link: https://pure.eur.nl/en/p..

3

Clinical practice guidelines for esophagogastric junction c..:

Kitagawa, Yuko ; Matsuda, Satoru ; Gotoda, Takuji...
https://pure.eur.nl/en/publications/10072edf-e4af-4e63-b38f-8317ebd73894. , 2024

Link: https://pure.eur.nl/en/p..

4

Association between gene expression signatures and clinical..:

Shitara, Kohei ; Di Bartolomeo, Maria ; Mandala, Mario...
Journal For Immunotherapy of Cancer. , 2023

Link: https://doi.org/10.1136/..

5

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gas..:

Shah, Manish A ; Shitara, Kohei ; Ajani, Jaffer A...
Nature Medicine, Vol.29 No.8, pp.2133-2141. , 2023

Link: https://hdl.handle.net/1..

6

Association between gene expression signatures and clinical..:

Shitara, Kohei ; Di Bartolomeo, Maria ; Mandala, Mario...
qt0bv8p41t. , 2023

Link: https://escholarship.org..

7

ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Pati..:

Klempner, Samuel J ; Lee, Keun-Wook ; Shitara, Kohei...
Clinical Cancer Research, Vol.29 No.19, pp.3882-3891. , 2023

Link: https://hdl.handle.net/1..

8

INTEGRATE II: randomised phase III controlled trials of reg..:

Lam, Lyn Ley ; Pavlakis, Nick ; Shitara, Kohei...
BMC Cancer, Vol.23 No.1, p. 12885. , 2023

Link: https://hdl.handle.net/1..

9

Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Facto..:

Yamaguchi, Kensei ; Bang, Yung-Jue ; Iwasa, Satoru...
Journal of Clinical Oncology, Vol.41 No.4, pp.816-825. , 2023

Link: https://hdl.handle.net/1..

10

INTEGRATE II: randomised phase III controlled trials of reg..:

Lam, Lyn Ley ; Pavlakis, Nick ; Shitara, Kohei...
BMC Cancer, 23(1):180. , 2023

Link: https://hdl.handle.net/1..

11

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positi..:

Shitara, Kohei ; Lordick, Florian ; Bang, Yung-Jue...
The Lancet, Vol.401 No.10389, pp.1655-1668. , 2023

Link: https://hdl.handle.net/1..

12

Randomized, Double-Blind, Placebo-Controlled Phase III Stud..:

Shah, Manish A ; Shitara, Kohei ; Lordick, Florian...
Clinical Cancer Research, Vol.28 No.17, pp.3686-3694. , 2022

Link: https://hdl.handle.net/1..

13

Ascites and resistance to immune checkpoint inhibition in d..:

Fucà, Giovanni ; Cohen, Romain ; Lonardi, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2021-004001. , 2022

Link: https://hal.sorbonne-uni..

14

Pooled safety analysis from phase III studies of trifluridi..:

Van Cutsem, Eric ; Hochster, Howard S ; Shitara, Kohei...
ESMO Open;7(6). , 2022

Link: https://hdl.handle.net/1..

15

Ascites and resistance to immune checkpoint inhibition in d..:

Fucà, Giovanni ; Cohen, Romain ; Lonardi, Sara...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2021-004001. , 2022

Link: https://hal.sorbonne-uni..